Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.195 USD | +3.49% | +1.76% | -42.05% |
07/05 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
02/05 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.05% | 72Cr | |
+4.52% | 11TCr | |
+10.99% | 11TCr | |
-11.96% | 2.23TCr | |
-3.76% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-9.23% | 1.7TCr | |
+3.17% | 1.37TCr | |
+36.44% | 1.24TCr |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- HC Wainwright Adjusts Aurinia Pharmaceuticals' Price Target to $26 from $30, Keeps Buy Rating